Jun N-terminal kinase in rheumatoid arthritis

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 124-130

  Han, Zuoning ^a   Boyle, David L ^a   Aupperle, Karlfried R ^a   Bennett, Brydon ^b   Manning, Anthony M ^b   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMINO ACID; COLLAGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1; JUN N TERMINAL KINASE; MITOGEN ACTIVATED PROTEIN KINASE; P38 KINASE; RAF PROTEIN; RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT DESTRUCTION; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ARTHRITIS, RHEUMATOID; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COLLAGENASES; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMANS; IMIDAZOLES; INTERLEUKIN-1; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOARTHRITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN ISOFORMS; PYRIDINES; SYNOVIAL MEMBRANE; TIME FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 0032872521     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alvaro-Gracia JM, Zvaifler NJ and Firestein GS (1990) Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between IFN-γ and TNF-α on HLA-DR expression, proliferation, collagenase production, and GM-CSF production by rheumatoid arthritis synoviocytes. J Clin Invest 86:1790-1798.
2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH and Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
3. Asahara H, Fujisawa K, Kobata T, Hasunuma T, Maeda T, Asanuma M, Ogawa N, Inoue H, Sumida T and Nishioka K (1997) Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum 40:912-918.
4. Boyle DL, Han Z, Rutter J, Brinckerhoff CE and Firestein GS (1997) Post-transcriptional regulation of collagenase gene expression in synoviocytes by adenosine receptor stimulation. Arthritis Rheum 40:1772-1779.
5. Bucala R, Ritchlin C, Winchester R and Cerami A (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173:569-574.
6. Casanova E, Garate C, Ovalle S, Calvo P and Chinchetru MA (1996) Identification of four splice variants of the mouse stress-activated protein kinase JNK/SAPK alpha-isoform. Neuroreport 7:1320-1324.
7. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
8. de Laszlo SE, Visco D, Agarwal L, Chang L, Chin J, Croft G, Forsyth A, Fletcher D, Frantz B, Hacker C, Hanlon W, Harper C, Kostura M, Li B, Luell S, MacCoss M, Mantlo N, O'Neill EA, Orevillo C, Pang M, Parsons J, Rolando A, Sahly Y, Sidler K and O'Keefe SJ (1998) Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett 8:2689-2694.
9. Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ and Flavell RA (1998) Defective T cell differentiation in the absence of Jnk1. Science (Wash DC) 282: 2092-2095.
10. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AH (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
11. Firestein GS (1996) Etiology and pathogenesis of rheumatoid arthritis, in Textbook of Rheumatology, 5th ed. (Kelley WN, Harris ED Jr, Ruddy S and Sledge CB eds) pp 851-897, W. B. Saunders Co., Philadelphia.
12. Firestein GS and Manning AM (1999) Signal transduction and transcription factors in rheumatic diseases. Arthritis Rheum 4:609-621.
13. Firestein GS and Paine MM (1992) Stromelysin and tissue inhibitor of metalloproteinases (TIMP) gene expression in rheumatoid arthritis synovium. Am J Pathol 140:1309-1314.
14. Firestein GS, Paine M and Littman BH (1991) Gene expression (collagenase, tissue inhibitor of metalloproteinase, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: Quantitative analysis and effect of intra-articular corticosteroids. Arthritis Rheum 34:1094-1105.
15. Firestein GS and Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33:768-773.
16. Gum R, Wang H, Lengyel E, Juarez J and Boyd D (1997) Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14:1481-1493.
17. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B and Davis RJ (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15:2760-2770.
18. Han Z, Boyle DL, Manning AM and Firestein GS (1998) AP-1 and NF-kB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197-208.
19. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R and Karin M (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8:2996-3007.
20. Karin M (1998) Mitogen-activated protein kinase cascades as regulators of stress responses. Ann NY Acad Sci 861:139-146.
21. Karin M, Liu Z and Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9:240-246.
22. Kumkumian GK, Lafyatis R, Remmers EF, Case JP, Kim SJ and Wilder RL (1989) Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. J Immunol 143:833-837.
23. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR and Landvatter SW (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (Lond) 372:739-746.
24. McCachren SS, Haynes BF and Niedel JE (1990) Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol 10:19-27.
25. Minden A and Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333:F85-F104.
26. Minden A, Lin A, Smeal T, Derijard B, Cobb M, Davis R and Karin M (1994) c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 14: 6683-6688.
27. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE and Gay S (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149:1607-1615.
28. Okamoto K, Fujisawa K, Hasunuma T, Kobata T, Sumida T and Nishioka K (1997) Selective activation of the JNK/AP-1 pathway in Fas-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum 40:919-926.
29. Pendas AM, Balbin M, Llano E, Jimenez MG and Lopez-Otin C (1997) Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 40:222-233.
30. Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE and Kahari VM (1998) Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 273:5137-5145.
31. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL and Saklatvala J (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 158:3165-3173.
32. Rutter JL, Benbow U, Coon CI and Brinckerhoff CE (1997) Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 β (IL-1β) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 66:322-336.
33. Seger R and Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735.
34. Simon C, Goepfert H and Boyd D (1998) Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 58:1135-1139.
35. Werlen G, Jacinto E, Xia Y and Karin M (1998) Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J 17:3101-3111.
36. Westwick JK, Weitzel C, Minden A, Karin M and Brenner DA (1994) Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 269:26396-26401.
37. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD and Davis RJ (1997) Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17:2360-2371.